BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33414079)

  • 1. Nomogram Predicting the Risk of Locoregional Recurrence After Mastectomy for Invasive Micropapillary Carcinoma of the Breast.
    Meng X; Ma H; Yin H; Yin H; Yu L; Liu L; Li T; Wang S; Xu Q
    Clin Breast Cancer; 2021 Aug; 21(4):e368-e376. PubMed ID: 33414079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nomogram for predicting locoregional recurrence in primary breast cancer patients who received breast-conserving surgery after neoadjuvant chemotherapy.
    Matsuda N; Hayashi N; Ohde S; Yagata H; Kajiura Y; Yoshida A; Suzuki K; Nakamura S; Tsunoda H; Yamauchi H
    J Surg Oncol; 2014 Jun; 109(8):764-9. PubMed ID: 24647874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomogram for predicting preoperative lymph node involvement in patients with invasive micropapillary carcinoma of breast: a SEER population-based study.
    Ye FG; Xia C; Ma D; Lin PY; Hu X; Shao ZM
    BMC Cancer; 2018 Nov; 18(1):1085. PubMed ID: 30409127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel nomogram for predicting locoregional recurrence risk in breast cancer patients treated with neoadjuvant chemotherapy and mastectomy.
    Huang Z; Shi M; Wang WH; Shen LF; Tang Y; Rong QL; Zhu L; Huang XB; Tie J; Chen JY; Zhang J; Wu HF; Cheng J; Liu M; Ma CY; Wang SL; Li YX
    Radiother Oncol; 2021 Aug; 161():191-197. PubMed ID: 34119586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomograms for predicting overall survival and cancer-specific survival in patients with invasive micropapillary carcinoma: Based on the SEER database.
    Zhang T; Lai M; Wei Y; Zhu H; Zhu C; Guo Y; Zeng X
    Asian J Surg; 2023 Sep; 46(9):3734-3740. PubMed ID: 36933963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and Validation of a Nomogram Predicting the Overall Survival Benefit of Unilateral Breast Cancer Patients Undergoing Contralateral Prophylactic Mastectomy.
    Dai L; Yan W; Ren X; Liu D; Chang L; Lin S; Wu H; Kang H; Ma X
    Clin Breast Cancer; 2024 Jun; 24(4):351-362. PubMed ID: 38521702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram for predicting preoperative regional lymph nodes metastasis in patients with metaplastic breast cancer: a SEER population-based study.
    Zhang M; Wang B; Liu N; Wang H; Zhang J; Wu L; Zhao A; Wang L; Zhao X; Yang J
    BMC Cancer; 2021 May; 21(1):565. PubMed ID: 34001061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06).
    Yu JI; Choi DH; Huh SJ; Cho EY; Kim K; Chie EK; Ha SW; Park IA; Ahn SJ; Lee JS; Shin KH; Kwon Y; Kim YB; Suh CO; Koo JS; Kim JH; Jeong BG; Kim IA; Lee JH; Park W
    Clin Breast Cancer; 2015 Oct; 15(5):353-61.e1-2. PubMed ID: 25776197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prognostic nomogram based on risk assessment for invasive micropapillary carcinoma of the breast after surgery.
    Chen Y; Yu C; Chen D; Tang Y; Zhu K; Guo R; Huang S; Li Z; Cen L
    Cancer Med; 2023 Apr; 12(7):8050-8062. PubMed ID: 36602294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomogram Predicting Locoregional Recurrence to Assist Decision-Making of Postmastectomy Radiation Therapy in Patients With T1-2N1 Breast Cancer.
    Luo C; Zhong X; Deng L; Xie Y; Hu K; Zheng H
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):905-912. PubMed ID: 30419307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy.
    Wang SB; Qi WX; Chen JY; Xu C; Kirova YM; Cao WG; Cai R; Cao L; Yan M; Cai G
    Radiat Oncol; 2019 Jul; 14(1):128. PubMed ID: 31315683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.
    Mamounas EP; Anderson SJ; Dignam JJ; Bear HD; Julian TB; Geyer CE; Taghian A; Wickerham DL; Wolmark N
    J Clin Oncol; 2012 Nov; 30(32):3960-6. PubMed ID: 23032615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram predicting survival as a selection criterion for postmastectomy radiotherapy in patients with T1 to T2 breast cancer with 1 to 3 positive lymph nodes.
    Tang Y; Zhang YJ; Zhang N; Shi M; Wen G; Cheng J; Wang HM; Liu M; Wang XH; Guo QS; Wu HF; Ma CY; Jin J; Liu YP; Song YW; Fang H; Ren H; Wang SL; Li YX
    Cancer; 2020 Aug; 126 Suppl 16():3857-3866. PubMed ID: 32710662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
    Mamtani A; Patil S; Stempel MM; Morrow M
    Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a risk scoring system for predicting locoregional recurrence in T1 to T2 node-negative breast cancer patients treated with mastectomy: Implications for postoperative radiotherapy.
    Li JL; Lin XY; Zhuang LJ; He JY; Peng QQ; Dong YP; Wu JX
    Medicine (Baltimore); 2017 Jun; 96(26):e7343. PubMed ID: 28658151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a Novel Nomogram for Prediction of Local Relapse after Surgery for Invasive Breast Carcinoma.
    Corso G; Maisonneuve P; Massari G; Invento A; Pravettoni G; De Scalzi A; Intra M; Galimberti V; Morigi C; Lauretta M; Sacchini V; Veronesi P
    Ann Surg Oncol; 2020 Jun; 27(6):1864-1874. PubMed ID: 31965372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting breast cancer recurrence following breast-conserving therapy: a single-institution analysis consisting of 764 Chinese breast cancer cases.
    Li S; Yu KD; Fan L; Hou YF; Shao ZM
    Ann Surg Oncol; 2011 Sep; 18(9):2492-9. PubMed ID: 21360247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breast.
    Cheng Y; Zhang P; Huang Y; Zhang Z; Tang R; Chi F; Sun JY; He Z
    BMJ Open; 2023 Feb; 13(2):e065312. PubMed ID: 36810178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Micropapillary Component Ratio on the Prognosis of Patients With Invasive Micropapillary Breast Carcinoma.
    Kaya C; Uçak R; Bozkurt E; Ömeroğlu S; Kartal K; Yazıcı P; İdiz UO; Mihmanlı M
    J Invest Surg; 2020 Jan; 33(1):31-39. PubMed ID: 29843540
    [No Abstract]   [Full Text] [Related]  

  • 20. Nomogram for Predicting the Overall Survival of Patients With Breast Cancer With Pathologic Nodal Status N3.
    Wang J; Chen L; Nie Y; Wu W; Yao Y
    Clin Breast Cancer; 2020 Dec; 20(6):e778-e785. PubMed ID: 32636150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.